AbbVie(NYSE:ABBV) stock has been a solid performer from the fourth-quarter lows, ripping from about $80 to more than $100 by the end of the year. Range support has been coming into play near $102, while bulls have had trouble sustaining price moves over $110. Wednesday’s sharp decli...
The steep uptrend that has taken root in the popular iShares 20+ Year Treasury Bond ETF (NYSEARCA:TLT) was bound to lose steam sometime. And it looks like that sometime is now. With gravity now exerting some influence on bond prices, two-sided price action has returned. And more ...